Trials / Completed
CompletedNCT04418388
Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women
A Single Center, Open-label Clinical Trial to Evaluate Pharmacokinetic Characteristics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Pharmbio Korea Co., Ltd. · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to assess the pharmacokinetic characteristics after a single dose of oral PBK-1801 in healthy Korean women for preparing the bridging data for Koreans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PBK-1801 | Administered orally |
| DRUG | PBK-1801 | Administered orally |
| DRUG | PBK-1801 | Administered orally |
Timeline
- Start date
- 2019-10-24
- Primary completion
- 2019-12-03
- Completion
- 2019-12-23
- First posted
- 2020-06-05
- Last updated
- 2020-06-05
Locations
1 site across 1 country: South Korea
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04418388. Inclusion in this directory is not an endorsement.